Enliven Therapeutics to Present at Upcoming Investor Conferences

Rhea-AI Summary

Enliven Therapeutics (Nasdaq: ELVN) announced participation in two upcoming investor conferences. Management will join fireside chats at the TD Cowen Annual Oncology Innovation Summit on May 27 at 2:30 p.m. ET and the Jefferies Global Healthcare Conference on June 4 at 11:40 a.m. ET.

Live webcasts and 90-day replays will be available via the company's investor relations website.

News Market Reaction – ELVN

-1.68%

-1.68% Session close to close

In the May 22 session, ELVN declined 1.68%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BOULDER, Colo., May 21, 2026 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that management will participate in the following investor conferences:

TD Cowen Annual Oncology Innovation Summit: Insights for ASCO & EHA
Format: Fireside Chat
Date: Wednesday, May 27
Time: 2:30 p.m. ET

Jefferies Global Healthcare Conference
Format: Fireside Chat
Date: Thursday, June 4
Time: 11:40 a.m. ET

The fireside chats will be webcast live and can be accessed by visiting the investor relations section of the Company's website at https://ir.enliventherapeutics.com/. The webcast will be archived for a period of 90 days following the conclusion of the live event.

About Enliven Therapeutics
Enliven is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics to help people not only live longer, but live better. Enliven aims to address existing and emerging unmet needs with a precision medicine approach that improves survival and enhances overall well-being. Enliven's discovery process combines deep insights into clinically validated biological targets and differentiated chemistry to design potentially first-in-class or best-in-class therapies. To learn more, visit www.enliventherapeutics.com and connect with us on LinkedIn and X.

View original content to download multimedia:https://www.prnewswire.com/news-releases/enliven-therapeutics-to-present-at-upcoming-investor-conferences-302779411.html

SOURCE Enliven Therapeutics, Inc.

FAQ

When will Enliven Therapeutics (Nasdaq: ELVN) present at the TD Cowen Oncology Innovation Summit?

Enliven Therapeutics will present at the TD Cowen Annual Oncology Innovation Summit on May 27 at 2:30 p.m. ET. According to the company, this appearance will be in a fireside chat format and webcast live for investors.

What are the details of Enliven Therapeutics (ELVN) presentation at the Jefferies Global Healthcare Conference?

Enliven Therapeutics plans a fireside chat at the Jefferies Global Healthcare Conference on June 4 at 11:40 a.m. ET. According to the company, the session will be webcast live for investors through its investor relations website.

How can investors watch Enliven Therapeutics (ELVN) investor conference webcasts?

Investors can watch Enliven Therapeutics conference webcasts via the investor relations section of the company’s website. According to the company, both fireside chats will stream live and be archived online for on-demand viewing.

Will replays of Enliven Therapeutics (ELVN) May 27 and June 4 fireside chats be available?

Yes, replays of both Enliven Therapeutics fireside chats will be available. According to the company, the webcasts will be archived on its investor relations website for 90 days after each live event, allowing flexible access for shareholders.

What format will Enliven Therapeutics (ELVN) use for its upcoming investor conference appearances?

Enliven Therapeutics will use a fireside chat format for both upcoming investor conference appearances. According to the company, these informal discussions at TD Cowen and Jefferies will be accessible to investors via live webcast and archived replay.